Kangji Medical Holdings Limited Fundamental Analysis
Kangji Medical Holdings Limited Fundamental Analysis
Kangji Medical Holdings Limited (9997.HK) shows strong financial fundamentals with a PE ratio of 16.67, profit margin of 53.63%, and ROE of 21.49%. The company generates $1.0B in annual revenue with moderate year-over-year growth of 8.92%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 74.5/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze 9997.HK's fundamental strength across five key dimensions:
Efficiency Score
Excellent9997.HK demonstrates superior asset utilization.
Valuation Score
Moderate9997.HK shows balanced valuation metrics.
Growth Score
Excellent9997.HK delivers strong and consistent growth momentum.
Financial Health Score
Excellent9997.HK maintains a strong and stable balance sheet.
Profitability Score
Excellent9997.HK achieves industry-leading margins.
Key Financial Metrics
Is 9997.HK Expensive or Cheap?
P/E Ratio
9997.HK trades at 16.67 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, 9997.HK's PEG of 2.90 indicates potential overvaluation.
Price to Book
The market values Kangji Medical Holdings Limited at 3.61 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 18.02 times EBITDA. This signals the market has high growth expectations.
How Well Does 9997.HK Make Money?
Net Profit Margin
For every $100 in sales, Kangji Medical Holdings Limited keeps $53.63 as profit after all expenses.
Operating Margin
Core operations generate 56.48 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $21.49 in profit for every $100 of shareholder equity.
ROA
Kangji Medical Holdings Limited generates $18.37 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Kangji Medical Holdings Limited generates strong operating cash flow of $537.92M, reflecting robust business health.
Free Cash Flow
Kangji Medical Holdings Limited generates strong free cash flow of $485.70M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.41 in free cash annually.
FCF Yield
9997.HK converts 5.18% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
16.67
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
2.90
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.61
vs 25 benchmark
P/S Ratio
Price to sales ratio
8.94
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
5.14
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.21
vs 25 benchmark
ROA
Return on assets percentage
0.18
vs 25 benchmark
ROCE
Return on capital employed
0.23
vs 25 benchmark
How 9997.HK Stacks Against Its Sector Peers
| Metric | 9997.HK Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 16.67 | 29.01 | Better (Cheaper) |
| ROE | 21.49% | 730.00% | Weak |
| Net Margin | 53.63% | -53564.00% (disorted) | Strong |
| Debt/Equity | 0.00 | 0.39 | Strong (Low Leverage) |
| Current Ratio | 5.14 | 4.47 | Strong Liquidity |
| ROA | 18.37% | -18932.00% (disorted) | Strong |
9997.HK outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Kangji Medical Holdings Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
74.93%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
145.93%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
50.10%
Industry Style: Defensive, Growth, Innovation
High Growth